Purchase Order 36C24226P0796

Veterans Integrated Service Network 5 awarded a purchase order to Theracom, L.L.C. for TAKHZYRO 150 MG with a ceiling value of $38,097.52 on April 14, 2026, with completion by April 17, 2026. The order carries no set-aside designation. Place of performance is Brooks, Kentucky. This firm fixed-price purchase order procures the specialized biologic pharmaceutical TAKHZYRO (lanadelumab) for the Department of Veterans Affairs healthcare system. Theracom is a pharmaceutical supply vendor and a...

<p>The Veterans Integrated Service Network 2 awarded a purchase order to Theracom, L.L.C. for $38,875.02 on May 20, 2026, with completion by May 27, 2026. The order is for TAKHZYRO 150MG/ML injection in 2ML syringe formulation. Performance occurs at Brooks, Kentucky. No set-aside was used. Theracom is a child entity of Cencora, Inc. (Amerisourcebergen) and specializes in supplying specialized pharmaceutical therapies to federal healthcare systems.</p>

Veterans Integrated Service Network 5 (VISN 5) of the Department of Veterans Affairs awarded a purchase order to Theracom, L.L.C. for TAKHZYRO 150 mg with a ceiling value of $38,097.52 on June 22, 2026, with ultimate completion by June 24, 2026. No set-aside was used. Performance occurs at Brooks, Kentucky. Theracom, a pharmaceutical supply specialist headquartered in Kentucky and a child entity of Cencora, Inc., supplies specialized biologic medications to federal healthcare systems. The firm...

The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2) awarded a $38,875.02 firm fixed-price purchase order to Theracom, L.L.C. on March 18, 2026 for the supply of TAKHZYRO 150MG/ML injection in 2ML syringe formulation. The contract, which will be completed by March 25, 2026, was awarded without a set-aside designation and will be performed at Theracom's location in Brooks, Kentucky. Theracom is a specialty pharmaceutical distributor headquartered in Shepherdsville,...

<p>The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a purchase order to Theracom, L.L.C. for TAKHZYRO 150 MG with a ceiling value of $38,097.52 on May 19, 2026, with completion by May 20, 2026. No set-aside was used. Performance occurs at Brooks, Kentucky. The order is firm fixed-price for the supply of this specialized pharmaceutical therapy to the federal healthcare system.</p>

The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2) awarded a firm fixed-price purchase order to Theracom, L.L.C. for TAKHZYRO 150MG/ML injection in 2ML syringe formulation on February 24, 2026. The contract has a ceiling value of $38,875.02 with an ultimate completion date of March 24, 2026. The award was made without a set-aside designation, reflecting full and open competition. Theracom, a Kentucky-based pharmaceutical specialty distributor headquartered in...

<p>The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a purchase order to Theracom, L.L.C. for TAKHZYRO 150 MG with a ceiling value of $38,097.52 on July 2, 2026, with completion by July 7, 2026. No set-aside was used. Performance occurs at Brooks, Kentucky. The order is for supply of the specialized pharmaceutical therapy TAKHZYRO (lanadelumab) as a firm fixed-price commercial purchase.</p>

The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a firm fixed-price purchase order to Theracom, L.L.C. for $38,097.52 for the supply of TAKHZYRO 150 MG, a specialized biologic pharmaceutical therapy. The contract was awarded on March 2, 2026, with an ultimate completion date of March 4, 2026, and no set-aside designation was utilized. Theracom, headquartered in Shepherdsville, Kentucky and operating from its Brooks, Kentucky facility, is a specialized...

Theracom, L.L.C., a child entity, has been awarded a firm fixed price purchase order by the Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs, for the supply of TAKHZYRO 150MG. The contract, issued on December 1, 2025, carries a ceiling value of $75,478.12 and is scheduled for ultimate completion by December 30, 2025. The contract was awarded without a set-aside designation and will be performed in Brooks, Kentucky. TAKHZYRO...

Theracom, L.L.C., a child entity, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 2 on October 20, 2025, for the supply of TAKHZYRO (pegtanercept) 150MG/ML injection in a 2ML syringe formulation. This is a pharmaceutical supply contract with a ceiling value of approximately $37.7K, with an ultimate completion date of November 20, 2025. The contract was awarded without a set-aside designation, and the place of performance is listed as Brooks, Kentucky. This...